The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis

Avacopan exhibits favorable real-world safety with no high-priority AEs identified. Our findings may provide important evidence for future clinical research and the management of safety issues related to avacopan.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-10-08
DOI
https://doi.org/10.3389/fimmu.2025.1654735
Citations
1
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis

Y Wang, Yang Li, А. А. Менг
1 citations
Frontiers in Immunology
Vasculitis and related conditions
1.52
article

The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis

Y Wang, Yang Li, А. А. Менг
article en
1 citations

Abstract

Avacopan exhibits favorable real-world safety with no high-priority AEs identified. Our findings may provide important evidence for future clinical research and the management of safety issues related to avacopan.

Frontiers in ImmunologyVol. 16
Nanjing Traditional Chinese Medicine Hospital (CN), Nanjing Medical University (CN)
Openalex Percentile: Top 14%
Vasculitis and related conditions
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.